Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annual Review of Public Health

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Computer Science, Economics

• Identifiers
  DOI 10.1146/ANNUREV.PUBLHEALTH.23.100901.140534PMID 11910068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combat-related bridge synostosis versus traditional transtibial amputation: comparison of military-specific outcomes

  2015cited by this paper
• Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis.

  2002cited by this paper
• Incremental net benefit in randomized clinical trials

  2001cited by this paper
• The death of cost-minimization analysis?

  2001cited by this paper
• Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: Results From the Canadian Implantable Defibrillator Study (CIDS)

  2001influential reference
• Design issues for conducting cost-effectiveness analyses alongside clinical trials.

  2001cited by this paper
• A BAYESIAN APPROACH TO STOCHASTIC COST-EFFECTIVENESS ANALYSIS

  2001cited by this paper
• Effect of Clinical Risk Stratification on Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: The Canadian Implantable Defibrillator Study

  2001cited by this paper
• Estimating log models: to transform or not to transform?

  2001cited by this paper
• Linear regression analysis of censored medical costs.

  2000cited by this paper
• Definition, interpretation and calculation of cost-effectiveness acceptability curves.

  2000cited by this paper
• A regression-based method for estimating mean treatment cost in the presence of right-censoring.

  2000cited by this paper
• Estimating medical costs with censored data

  2000cited by this paper
• Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio

  2000cited by this paper
• Fieller's method and net health benefits.

  2000cited by this paper
• Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation.

  1999cited by this paper
• UNCERTAINTY OF INCREMENTAL COST-EFFECTIVENESS RATIOS

  1999cited by this paper
• A Bayesian approach to stochastic cost-effectiveness analysis.

  1999cited by this paper
• Redefining the analytical approach to pharmacoeconomics.

  1999cited by this paper
• Bayesian estimation of cost-effectiveness ratios from clinical trials.

  1999cited by this paper
• On the use of survival analysis techniques to estimate medical care costs.

  1999cited by this paper
• The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.

  1999influential reference
• ECONOMIC EVALUATION OF DIAGNOSTIC TESTS

  1999cited by this paper
• Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.

  1998cited by this paper
• The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation

  1998cited by this paper
• Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

  1998cited by this paper
• A Note on Confidence Intervals in Cost-Effectiveness Analysis

  1998influential reference
• Much ado about two: reconsidering retransformation and the two-part model in health econometrics.

  1998cited by this paper
• Net Health Benefits

  1998cited by this paper
• Predicting the Cost of Illness

  1998cited by this paper
• Sequence Effects, Health Profiles, and the QALY Model

  1998cited by this paper
• Carrier screening for cystic fibrosis: costs and clinical outcomes.

  1998cited by this paper
• Treatment of Early-Stage Breast Cancer in the Elderly

  1998cited by this paper
• Sample size calculation in economic evaluations.

  1998cited by this paper
• On estimating costs for economic evaluation in failure time studies.

  1998cited by this paper
• Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis

  1998cited by this paper
• Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40

  1998cited by this paper
• Trends in Economic Evaluation

  1998cited by this paper
• A Comparison of Alternative Models Applied to Stroke

  1998cited by this paper
• Bayesians and frequentists

  1998cited by this paper
• Confidence intervals for cost-effectiveness ratios: a comparison of four methods.

  1997cited by this paper
• Estimating medical costs from incomplete follow-up data.

  1997cited by this paper
• The negative side of cost-effectiveness analysis.

  1997cited by this paper
• Bootstrap Analyses of Cost Effectiveness in Antidepressant Pharmacotherapy

  1997cited by this paper
• Elevated cerebrospinal fluid glutamate in patients with HIV-related dementia.

  1997cited by this paper
• Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

  1997cited by this paper
• An economic approach to clinical trial design and research priority-setting.

  1996influential reference
• BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS

  1996cited by this paper
• Modelling programme costs in economic evaluation.

  1996cited by this paper
• Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

  1996cited by this paper
• Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

  1996cited by this paper
• Statistics notes: Absence of evidence is not evidence of absence

  1995cited by this paper
• Absence of evidence is not evidence of absence.

  1995cited by this paper
• The Analysis of Censored Treatment Cost Data in Economic Evaluation

  1995cited by this paper
• Statistical Versus Quantitative Significance in the Socioeconomic Evaluation of Medicines

  1994cited by this paper
• Costs, effects and C/E-ratios alongside a clinical trial.

  1994cited by this paper
• In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care

  1994cited by this paper
• A Consumer's Guide to Subgroup Analyses

  1992cited by this paper
• The CE Plane

  1990cited by this paper
• Methods for the economic evaluation of health care programmes

  1987cited by this paper
• Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews.

  1987cited by this paper
• The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

  1978cited by this paper
• SOME PROBLEMS IN INTERVAL ESTIMATION

  1954influential reference

• Cost-effectiveness of targeted feedback interventions after depression screening in primary care: health economic evaluation of the GET.FEEDBACK.GP trial

  2026cites this paper
• Cost-effectiveness of spinal manipulation, exercise, and self-management for spinal pain

  2025cites this paper
• Cost-utility analysis of Add-on SGLT2 Inhibitors for Heart failure with reduced ejection fraction in India

  2025cites this paper
• Cost‐effectiveness of a multicomponent intervention against cognitive decline

  2025cites this paper
• Cost‐Utility Analysis of a Group Mindfulness Program Compared to an Education Support Program for Breast Cancer Survivors With Cognitive Impairment: Evidence From a Randomized Controlled Trial

  2025cites this paper
• Cost-Effectiveness of In-Bed Cycling and Routine Physiotherapy for Patients Receiving Mechanical Ventilation

  2025cites this paper
• Economic Evaluation of a Problem-Solving Intervention With Workplace Involvement Among Employees With Common Mental Disorder in Swedish Primary Care: Results From a Cluster-Randomized Controlled Trial.

  2025cites this paper
• Enhancing Naloxone Distribution for Opioid Users in the USA: A Cost-Utility Analysis of Academic Detailing to Clinicians

  2025cites this paper
• Cost-effectiveness of low-dose amitriptyline for irritable bowel syndrome in primary care

  2025cites this paper
• Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

  2024cites this paper
• Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy

  2024cites this paper
• Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT.

  2024cites this paper
• Cost-effectiveness analysis of health tapestry, a complex primary care program for older adults: a post-hoc analysis

  2024cites this paper
• Cost-utility of cochlear implantation in single-sided deafness and asymmetric hearing loss: results of a randomized controlled trial

  2024cites this paper
• Advantages of Monte Carlo Confidence Intervals for Incremental Cost-Effectiveness Ratios: A Comparison of Five Methods

  2024cites this paper
• Economic evaluation of an adjunctive intraocular and peri-ocular steroid vitreoretinal surgery for open globe trauma: Cost-effectiveness of the ASCOT randomised controlled trial

  2024cites this paper
• Economic evaluation of a trial exploring the effects of a web-based support tool for parents of children with juvenile idiopathic arthritis.

  2024cites this paper
• Cost-effectiveness of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: a systematic review and meta-analysis

  2024cites this paper
• Cost–utility analysis of a palliative care program in Colombia

  2024cites this paper
• Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocol

  2024cites this paper
• Smartphone-assisted training with education for patients with hip and/or knee osteoarthritis (SmArt-E): study protocol for a multicentre pragmatic randomized controlled trial

  2023cites this paper
• Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial

  2023cites this paper
• Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

  2023cites this paper
• Cost-effectiveness of School-based Caries Screening using Transillumination.

  2023cites this paper
• Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial.

  2023cites this paper
• Cost-Effectiveness of Unrelated Umbilical Cord Blood vs. HLA Haploidentical Related Bone Marrow Transplant: Evidence from BMT CTN 1101.

  2023cites this paper
• Cost-Effectiveness of the Mindfulness-Based Childbirth and Parenting Program for Pregnant Women With Fear of Childbirth.

  2023cites this paper
• Pharmacoeconomic issues in stem cell mobilization.

  2023cites this paper
• Extracorporeal carbon dioxide removal compared to ventilation alone in patients with acute hypoxaemic respiratory failure: cost-utility analysis of the REST RCT.

  2023cites this paper
• Cost‐effectiveness of closed incision negative pressure wound therapy in preventing surgical site infection among obese women giving birth by caesarean section: An economic evaluation (DRESSING trial)

  2023cites this paper
• Cost-effectiveness analysis of full versus selective root canal retreatment.

  2023cites this paper
• Cost-effectiveness of providing university students with a mindfulness-based intervention to reduce psychological distress: economic evaluation of a pragmatic randomised controlled trial

  2023cites this paper
• Urinary catheter monitoring of intra-abdominal pressure after major abdominal surgery, a cost-benefit analysis

  2022cites this paper
• Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.

  2022cites this paper
• Economic evaluation: a reader’s guide to studies of cost-effectiveness

  2022cites this paper
• Understanding implementation costs of a pediatric weight management intervention: an economic evaluation protocol

  2022cites this paper
• The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland

  2022cites this paper
• Cost-effectiveness of AI for Caries Detection: Randomized Trial.

  2022cites this paper
• Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs

  2022cites this paper
• Artificial Intelligence for Caries Detection: Value of Data and Information

  2022cites this paper
• Letter to the Editor: Lazzaro responds to Rodríguez‑Sánchez et al.

  2022cites this paper
• Economic evaluation of return-to-work interventions for mental disorder-related sickness absence: two years follow-up of a randomized clinical trial

  2022cites this paper
• A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer.

  2022cites this paper
• The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review

  2022cites this paper
• The efficacy of automated feedback after internet-based depression screening: Study protocol of the German, three-armed, randomised controlled trial DISCOVER

  2021cites this paper
• Interpretation of trial-based economic evaluations of musculoskeletal physical therapy interventions.

  2021influential citation
• Multiple effects health economic evaluation of the Ahead of The Game Study for mental health promotion in sporting club communities

  2021cites this paper
• Are manual therapy or booster sessions worthwhile in addition to exercise therapy for knee osteoarthritis: Economic evaluation and 2-year follow-up of a randomized controlled trial.

  2021cites this paper
• Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study

  2021cites this paper
• Cost-Effectiveness and Cost-Utility of a Home-Based Exercise Program in Geriatric Patients with Cognitive Impairment

  2021cites this paper
• Longer-term health and social care strategies for stroke survivors and their carers: the LoTS2Care research programme including cluster feasibility RCT

  2021cites this paper
• Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia

  2021cites this paper
• Cost-effectiveness of home versus hospital management of children at onset of type 1 diabetes: the DECIDE randomised controlled trial

  2021cites this paper
• Cost-Effectiveness of a Web-Based Program for Residual Depressive Symptoms: Mindful Mood Balance.

  2021cites this paper
• Long-term Cost-Effectiveness of Glass Hybrid versus Composite in Permanent Molars.

  2021cites this paper
• Design and Rationale for the Deep South Interactive Voice Response System–Supported Active Lifestyle Study: Protocol for a Randomized Controlled Trial

  2021cites this paper
• Pharmacoeconomics

  2021cites this paper
• Social recovery therapy for young people with emerging severe mental illness: the Prodigy RCT.

  2021cites this paper
• Reducing Problematic Alcohol Use in Employees: Economic Evaluation of Guided and Unguided Web-Based Interventions Alongside a Three-arm Randomized Controlled Trial.

  2021cites this paper
• Cost-Effectiveness of a Group vs Individually Delivered Exercise Program in Community-Dwelling Persons Aged ≥70 Years.

  2021cites this paper
• A pilot economic evaluation of a feasibility trial for SUpporting wellbeing through PEeR-Befriending (SUPERB) for post-stroke aphasia

  2021cites this paper
• Strategies to enhance routine physical activity in care home residents: the REACH research programme including a cluster feasibility RCT

  2021cites this paper
• Colorectal Cancer Screening: Theory and Practical Application

  2021cites this paper
• Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression – a cluster-randomized trial

  2020cites this paper
• Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome

  2020cites this paper
• Considering the societal perspective in economic evaluations: a systematic review in the case of depression

  2020cites this paper
• Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia.

  2020cites this paper
• Cost-effectiveness of dual-energy CT versus multiphasic single-energy CT and MRI for characterization of incidental indeterminate renal lesions

  2020cites this paper
• A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis: a cost-effectiveness analysis.

  2020cites this paper
• Cost-effectiveness of preoperative magnetic resonance imaging to optimize surgery in ductal carcinoma in situ of the breast.

  2020cites this paper
• Venous stenting for patients with outflow obstruction and leg ulcers: cost-effectiveness and budget impact analyses.

  2020cites this paper
• On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers

  2020cites this paper
• Why it’s Time to Abandon the ICER

  2020cites this paper
• Calculating and Interpreting ICERs and Net Benefit

  2020cites this paper
• Economic evaluation of the integrated care model and its scalability in Zimbabwe

  2020cites this paper
• Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy

  2020cites this paper
• Translation of two healthy eating and active living support programs for parents of 2–6 year old children: a parallel partially randomised preference trial protocol (the ‘time for healthy habits’ trial)

  2020cites this paper
• Cost-Effectiveness Analysis of Colorectal Cancer Screening

  2020cites this paper
• An Outreach Rehabilitation Program for Nursing Home Residents after Hip Fracture may be Cost-Saving.

  2020cites this paper
• Maintaining pulpal vitality: Cost-effectiveness analysis on carious tissue removal and direct pulp capping.

  2020cites this paper
• Cost-effectiveness of Practice Team-Supported Exposure Training for Panic Disorder and Agoraphobia in Primary Care: a Cluster-Randomized Trial

  2020cites this paper
• Cost-effectiveness of Artificial Intelligence for Proximal Caries Detection

  2020cites this paper
• Protocol for a longitudinal study of melatonin therapy and cost effectiveness analysis in stimulant-treated children with ADHD and insomnia: An N-of-1 trial

  2020cites this paper
• Costs and benefits of intraoperative neurophysiological monitoring in spinal surgeries

  2020cites this paper
• Impact of SARS-CoV2 (Covid-19) on dental practices: Economic analysis

  2020cites this paper
• Cost-Effectiveness Analysis of Deep Brain Stimulation for Parkinson's Disease in Taiwan.

  2020cites this paper
• The Application and Implications of Novel Deterministic Sensitivity Analysis Methods

  2020cites this paper
• Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.

  2019influential citation
• Study protocol for the COMET study: a cluster-randomised, prospective, parallel-group, superiority trial to compare the effectiveness of a collaborative and stepped care model versus treatment as usual in patients with mental disorders in primary care

  2019cites this paper
• The safety, efficacy and cost-effectiveness of the Maxm Skate, a lower limb rehabilitation device for use following total knee arthroplasty: study protocol for a randomised controlled trial

  2019cites this paper
• Improving Blood Pressure Among African Americans With Hypertension Using a Mobile Health Approach (the MI-BP App): Protocol for a Randomized Controlled Trial

  2019cites this paper
• Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future.

  2019cites this paper
• AgeWell.de – study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients

  2019cites this paper
• Optimising neonatal service provision for preterm babies born between 27 and 31 weeks gestation in England (OPTI-PREM), using national data, qualitative research and economic analysis: a study protocol

  2019cites this paper
• Less Is More? The Long-Term Health and Cost Consequences Resulting from Minimal Invasive Caries Management.

  2019cites this paper
• Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study

  2019cites this paper
• Effectiveness of quality incentive payments in general practice (EQuIP-GP): a study protocol for a cluster-randomised trial of an outcomes-based funding model in Australian general practice to improve patient care

  2019cites this paper
• Les évaluations économiques en population dans les prises en charge des cancers : évaluation des coûts des lymphomes et de la leucémie myéloïde chronique

  2019cites this paper
• Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial

  2019cites this paper
• Cost‐Effectiveness of a Weight Loss Intervention: An Adaptation of the Look AHEAD Lifestyle Intervention in the US Military

  2019cites this paper